tm
Seeing Is Believing
tm
Seeing Is Believing
Homology Medicines's activity chart (see below) currently has 51 price targets and 47 ratings on display.
Analysts average stock forecasts to be materialized ratio is 42.42% with an average time for these price targets to be met of 198.36 days.
Most recent stock forecast was given by RICHARD LAW from CREDIT SUISSE on 15-Aug-2023. First documented stock forecast 24-Apr-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 28-Apr-2022
$36
3 years 2 months 6 days ago
(15-Aug-2023)
1/3 (33.33%)
$18.32 (103.62%)
98
Buy Since 28-Jul-2023
$9
$-0.56 (-5.86%)
$10
3 years 2 months 23 days ago
(28-Jul-2023)
3/6 (50%)
$-14.94 (-62.41%)
293
Buy Since 27-Feb-2022
$20
$10.44 (109.21%)
$20
3 years 5 months 6 days ago
(15-May-2023)
4/4 (100%)
$1.64 (8.93%)
153
Buy Since 16-Mar-2020
$7
$-2.56 (-26.78%)
3 years 5 months 9 days ago
(12-May-2023)
1/6 (16.67%)
$-10.68 (-60.41%)
313
Buy Since 30-Mar-2022
$7
$-2.56 (-26.78%)
$7.92
3 years 5 months 9 days ago
(12-May-2023)
4/4 (100%)
$-10.68 (-60.41%)
430
What is FIXX (Homology Medicines) average time for price targets to be met?
Which analyst most recently updated their price target on FIXX (Homology Medicines)?
Which analyst has the most public recommendations on FIXX (Homology Medicines)?
Which analyst is the currently most bullish on FIXX (Homology Medicines)?
Which analyst is the currently most reserved on FIXX (Homology Medicines)?
